Cancer is the leading cause of death in the United States, despite the fact that great advances have been made in its prevention and therapy. The growth of blood vessels in tumors is essential for their growth and metastasis. An attractive strategy for cancer therapy is to target cytotoxic agents to the endothelial cells lining tumor blood vessels rather than to the tumor cells themselves. One key advantage of this vascular targeting approach is that the endothelial cells are very accessible to agents injected into the blood whereas the tumor cells frequently are not. Genetically engineered tumor models that artificially induce selective marker expression on the tumor endothelium indicate that vascular targeting with immunotoxins and immuno-coagulants causes significant tumor regression. In order to implement this strategy, specific target sites need to be identified on the tumor endotheliurn. Tumor microenvironmental factors are expected to alter endothelial cell surface protein expression. Moreover, our recent work helps establish that specific transport vesicles, called caveolae, located on the endothelial cell surface contain tissue-specific proteins that when immunotargeted in vivo permit selective transport into and across the endothelial cell barrier. With these issues in mind, we believe that the vascular endothelium and caveolae in tumors are worthy of investigation at the molecular level. In this proposal, we focus on the effects of the tumor on the endothelium with the purpose of identifying caveolar proteins induced by the tumor that can be used as molecular targets for diagnostic and therapeutic probes. Proteins associated with the caveolae of the endothelium from normal tissue and from tumors will be resolved by utilizing novel membrane-isolation technique that isolate caveolae directly from tissues. The proteins in these caveolae will be comparatively analyzed and characterized. For the in vivo studies we will utilize a rat tumor model using rat and human breast adenocarcinoma cells. So far, we have identified several proteins in caveolae that are induced in tumors. Antibodies will be produced to these proteins in order to develop probes specific for the tumor blood vessels. These proteins will be analyzed by mass spectroscopy and if necessary, purified for amino acid microsequencing to determine their identity or novelty. The antibodies will be used to detect tumor growth and to immunolocalize the antigens in various normal and neoplastic tissues. Those antibodies specific for the tumor endothelium will be used not only to target the tumor vasculature in vivo but also to investigate their transport by caveolae in the tumor tissue. Because the tumor vasculature is critical for tumor growth, metastasis, and survival, a non-invasive, vector-mediated drug delivery system to the tumor will provide not only an accessible therapeutic modality but also a specific ablative approach to primary and metastatic cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA083989-03
Application #
6711115
Study Section
Pathology B Study Section (PTHB)
Program Officer
Sathyamoorthy, Neeraja
Project Start
2002-03-01
Project End
2007-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
3
Fiscal Year
2004
Total Cost
$441,440
Indirect Cost
Name
Sidney Kimmel Cancer Center
Department
Type
DUNS #
789644697
City
San Diego
State
CA
Country
United States
Zip Code
92121
Oh, Phil; Testa, Jacqueline E; Borgstrom, Per et al. (2014) In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors. Nat Med 20:1062-8
Chrastina, Adrian; Massey, Kerri A; Schnitzer, Jan E (2011) Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:421-37
Massey, Kerri A; Schnitzer, Jan E (2009) Targeting and imaging signature caveolar molecules in lungs. Proc Am Thorac Soc 6:419-30
Testa, Jacqueline E; Chrastina, Adrian; Li, Yan et al. (2009) Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res 46:311-24
Li, Yan; Yu, Jingyi; Wang, Yipeng et al. (2009) Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics 8:1219-35
Durr, Eberhard; Yu, Jingyi; Krasinska, Karolina M et al. (2004) Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 22:985-92